Deletion of the prorenin receptor in the ureteric bud in mice inhibits Dot1/H3K79 pathway

被引:1
|
作者
Song, Renfang [1 ]
Yosypiv, Ihor V. [1 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, Dept Pediat, Sect Pediat Nephrol, New Orleans, LA 70112 USA
关键词
KIDNEY; ATPASE; CELLS;
D O I
10.1038/s41390-024-03026-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The prorenin receptor (PRR) plays a critical role in ureteric bud (UB) branching morphogenesis. DOT1 Like (DOT1L), a histone methyltransferase specific for Histone 3 lysine 79 (H3K79), is important for differentiation of the UB-derived renal collecting duct cells. In this study, we tested whether DOT1L/H3 dimethyl K79 (H3m2K79) are regulated by PRR deletion in the UB and UB-derived collecting ducts in the embryonic mouse kidneys. Methods: Mutant Hoxb7(Cre+)/PRRflox/flox (PRRUB-/-) and control PRRUB+/+, mice were studied on embryonic (E) day E17.5. DOT1L mRNA and protein expression in the kidney was examined by real-time qRT-PCR and immunohistochemistry, respectively. H3m2K79 protein expression was determined by immunohistochemistry and Western blot analysis. Results: DOT1L mRNA levels were decreased in mutant compared to control mice (0.68 +/- 0.06 vs. 1.0 +/- 0.01, p < 0.01). DOT1L and H3m2K79 immunostaining was reduced in the mutant vs. control kidneys (Dot1: 0.62 +/- 0.03 vs. 1.0 +/- 0.01, p < 0.05; H3m2K79: 0.64 +/- 0.04 vs.1.1 +/- 0.01. p < 0.05.). Western blot analysis revealed decreased H3m2K79 protein levels in mutant compared to control kidneys (1.0 +/- 0.06 vs. 1.5 +/- 0.02, p < 0.05). Conclusion: Targeted deletion of the PRR in the UB and UB-derived collecting ducts results in reduced DOT1L gene/protein and H3m2K79 protein expression in the embryonic mouse metanephroi in vivo.<br />
引用
收藏
页码:1754 / 1757
页数:4
相关论文
共 50 条
  • [41] Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
    Deshpande, Aniruddha J.
    Chen, Liying
    Fazio, Maurizio
    Sinha, Amit U.
    Bernt, Kathrin M.
    Banka, Deepti
    Dias, Stuart
    Chang, Jenny
    Olhava, Edward J.
    Daigle, Scott R.
    Richon, Victoria M.
    Pollock, Roy M.
    Armstrong, Scott A.
    BLOOD, 2013, 121 (13) : 2533 - 2541
  • [42] Hesperetin promotes DOT1L degradation and reduces histone H3K79 methylation to inhibit gastric cancer metastasis
    Wang, Si-wei
    Sheng, Hao
    Zheng, Fang
    Zhang, Feng
    PHYTOMEDICINE, 2021, 84
  • [43] DEFICIENCY OF H3K79 METHYLTRANSFERASE DOT1L IN NEPHRON PROGENITOR CELLS CAUSES RENAL HYPO-DYSPLASIA
    Ngo, J.
    Li, Y.
    Chen, S.
    Yao, X.
    Liu, J.
    Saifudeen, Z.
    El-Dahr, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (02) : 418 - 419
  • [44] AF9 YEATS Domain Links Histone Acetylation to DOT1L-Mediated H3K79 Methylation
    Li, Yuanyuan
    Wen, Hong
    Xi, Yuanxin
    Tanaka, Kaori
    Wang, Haibo
    Peng, Danni
    Ren, Yongfeng
    Jin, Qihuang
    Dent, Sharon Y. R.
    Li, Wei
    Li, Haitao
    Shi, Xiaobing
    CELL, 2014, 159 (03) : 558 - 571
  • [45] A Medicinal Chemistry Perspective for Targeting Histone H3 Lysine-79 Methyltransferase DOT1 L
    Anglin, Justin L.
    Song, Yongcheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (22) : 8972 - 8983
  • [46] NPM1 Mutation Contributes to Hematological Dysfunction By Disrupting H3K79 Methylation
    Xu, Jie
    Zhang, Wu
    Yan, Xiaojing
    Zhao, Chen
    Zhu, Jiang
    Chen, Zhu
    Chen, Sai-Juan
    Hu, Jiong, Sr.
    BLOOD, 2016, 128 (22)
  • [47] THE HOMEOSTATIC HYPOXIC ENVIRONMENT IN ARTICULAR CARTILAGE SUSTAINS DOT1L ACTIVITY AND H3K79 METHYLATION TO PROTECT AGAINST OSTEOARTHRITIS
    De Roover, A.
    Nunez, A. Escribano
    Cornelis, F.
    Cherifi, C.
    Casas-Fraile, L.
    Sermon, A.
    Cailotto, F.
    Lories, R.
    Monteagudo, S.
    OSTEOARTHRITIS AND CARTILAGE, 2022, 30 : S155 - S156
  • [48] The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
    Stein, Eytan M.
    Garcia-Manero, Guillermo
    Rizzieri, David A.
    Tibes, Raoul
    Berdeja, Jesus G.
    Savona, Michael R.
    Jongen-Lavrenic, Mojca
    Altman, Jessica K.
    Thomson, Blythe
    Blakemore, Stephen J.
    Daigle, Scott R.
    Waters, Nigel J.
    Suttle, A. Benjamin
    Clawson, Alicia
    Pollock, Roy
    Krivtsov, Andrei
    Armstrong, Scott A.
    DiMartino, Jorge
    Hedrick, Eric
    Lowenberg, Bob
    Tallman, Martin S.
    BLOOD, 2018, 131 (24) : 2661 - 2669
  • [49] DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells
    Steger, David J.
    Lefterova, Martina I.
    Ying, Lei
    Stonestrom, Aaron J.
    Schupp, Michael
    Zhuo, David
    Vakoc, Adam L.
    Kim, Ja-Eun
    Chen, Junjie
    Lazar, Mitchell A.
    Blobel, Gerd A.
    Vakoc, Christopher R.
    MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (08) : 2825 - 2839
  • [50] Myeloid Leukemia Cells With MLL partial Tandem Duplication Are Sensitive To Pharmacological Inhibition Of The H3K79 Methyltransferase DOT1L
    Kuhn, Michael W. M.
    Hadler, Michael
    Daigle, Scott R.
    Chen, Chun-Wei
    Sinha, Amit U.
    Krivtsov, Andrei V.
    Olhava, Edward J.
    Caligiuri, Michael A.
    Bradner, James E.
    Pollock, Roy M.
    Armstrong, Scott A.
    BLOOD, 2013, 122 (21)